NGM707

DB28351InvestigationalProtein Based Therapies

NGM707 is a humanized IgG antibody with specificity for both LILRB1 and LILRB2.

Mechanism: Pharmacologically active on Leukocyte immunoglobulin-like receptor subfamily B member 1 and Leukocyte immunoglobulin-like receptor subfamily B member 2
Curator reviewed
Code names: NGM707

Resolves to

Targets

What you can answer from here — as of October 15, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with NGM707, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.